These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 805535)

  • 1. Use of a Pseudomonas Aeruginosa vaccine in pateints with acute leukemia and cystic fibrosis.
    Pennington JE; Reynolds HY; Wood RE; Robinson RA; Levine AS
    Am J Med; 1975 May; 58(5):629-36. PubMed ID: 805535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Lang AB; Schaad UB; Rüdeberg A; Wedgwood J; Que JU; Fürer E; Cryz SJ
    J Pediatr; 1995 Nov; 127(5):711-7. PubMed ID: 7472821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination of cystic fibrosis patients against Pseudomonas aeruginosa reduces the proportion of patients infected and delays time to infection.
    Lang AB; Rüdeberg A; Schöni MH; Que JU; Fürer E; Schaad UB
    Pediatr Infect Dis J; 2004 Jun; 23(6):504-10. PubMed ID: 15194830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary investigations of Pseudomonas aeruginosa vaccine in patients with leukemia and cystic fibrosis.
    Pennington JE
    J Infect Dis; 1974 Nov; 130 Suppl(0):S159-62. PubMed ID: 4213986
    [No Abstract]   [Full Text] [Related]  

  • 5. Prospective, controlled study of a polyvalent pseudomonas vaccine in cystic fibrosis--three year results.
    Langford DT; Hiller J
    Arch Dis Child; 1984 Dec; 59(12):1131-4. PubMed ID: 6441523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody responses induced by long-term vaccination with an octovalent conjugate Pseudomonas aeruginosa vaccine in children with cystic fibrosis.
    Zuercher AW; Horn MP; Que JU; Ruedeberg A; Schoeni MH; Schaad UB; Marcus P; Lang AB
    FEMS Immunol Med Microbiol; 2006 Jul; 47(2):302-8. PubMed ID: 16831219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccines for preventing infection with Pseudomonas aeruginosa in people with cystic fibrosis.
    Keogan MT; Johansen HK
    Cochrane Database Syst Rev; 2000; (2):CD001399. PubMed ID: 10796780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter vaccine trial using the Pseudomonas aeruginosa flagella vaccine IMMUNO in patients with cystic fibrosis.
    Döring G; Dorner F
    Behring Inst Mitt; 1997 Feb; (98):338-44. PubMed ID: 9382758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiological background for anti-Pseudomonas aeruginosa vaccination in cystic fibrosis.
    Bauernfeind A; Przyklenk B
    Behring Inst Mitt; 1997 Feb; (98):256-61. PubMed ID: 9382748
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunization of noncolonized cystic fibrosis patients against Pseudomonas aeruginosa.
    Cryz SJ; Wedgwood J; Lang AB; Ruedeberg A; Que JU; Fürer E; Schaad UB
    J Infect Dis; 1994 May; 169(5):1159-62. PubMed ID: 8169414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal administration of a Pseudomonas lipopolysaccharide vaccine in cystic fibrosis patients.
    Wood RE; Pennington JE; Reynolds HY
    Pediatr Infect Dis; 1983; 2(5):367-9. PubMed ID: 6415621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis.
    Johansen HK; Gøtzsche PC
    Cochrane Database Syst Rev; 2008 Oct; (4):CD001399. PubMed ID: 18843616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccinations against Pseudomonas aeruginosa: active and passive alternatives.
    Bellanti JA; Zeligs BJ; Kulczycki LL
    Pediatr Pulmonol Suppl; 1997; 16():269-70. PubMed ID: 9443307
    [No Abstract]   [Full Text] [Related]  

  • 14. Controlled prospective trial of Pseudomonas aeruginosa vaccine in children with acute leukemia.
    Haghbin M; Armstrong D; Murphy ML
    Cancer; 1973 Oct; 32(4):761-6. PubMed ID: 4201654
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety and immunogenicity of Pseudomonas aeruginosa conjugate A vaccine in cystic fibrosis.
    Schaad UB; Lang AB; Wedgwood J; Ruedeberg A; Que JU; Fürer E; Cryz SJ
    Lancet; 1991 Nov; 338(8777):1236-7. PubMed ID: 1682645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Döring G
    Int J Med Microbiol; 2010 Dec; 300(8):573-7. PubMed ID: 20940108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of pulmonary antibodies with induced sputum and bronchoalveolar lavage induced by nasal vaccination against Pseudomonas aeruginosa: a clinical phase I/II study.
    Baumann U; Göcke K; Gewecke B; Freihorst J; von Specht BU
    Respir Res; 2007 Aug; 8(1):57. PubMed ID: 17683588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients.
    Döring G; Meisner C; Stern M;
    Proc Natl Acad Sci U S A; 2007 Jun; 104(26):11020-5. PubMed ID: 17585011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled trials of a polyvalent pseudomonas vaccine in burns.
    Jones RJ; Roe EA; Gupta JL
    Lancet; 1979 Nov; 2(8150):977-82. PubMed ID: 91774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affinity constants of naturally acquired and vaccine-induced anti-Pseudomonas aeruginosa antibodies in healthy adults and cystic fibrosis patients.
    Bruderer U; Cryz SJ; Schaad UB; Deusinger M; Que JU; Lang AB
    J Infect Dis; 1992 Aug; 166(2):344-9. PubMed ID: 1634805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.